Fernando Martínez-Alzamora

Title: Innovations by Fernando Martínez-Alzamora

Introduction

Fernando Martínez-Alzamora is a notable inventor based in Alcobendas, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address various medical needs. With a total of 2 patents, his work showcases a commitment to improving patient care through innovative solutions.

Latest Patents

One of Martínez-Alzamora's latest patents is a pharmaceutical composition of ibuprofen and tramadol for ophthalmic use. This invention is designed to be effective and safe for treating ocular inflammation and pain associated with various diseases affecting the eye. It is particularly indicated for managing pain and inflammation following eye surgery.

Another significant patent is a pharmaceutical composition of sildenafil citrate in the form of a suspension for oral use. This composition includes water as a vehicle, along with xanthan gum and hypromellose as suspension agents. It is highly stable and effectively masks the bitter taste of the active ingredient. This formulation is suitable for treating masculine sexual dysfunction and includes a procedure for its preparation and a container equipped with a dosing device.

Career Highlights

Throughout his career, Fernando Martínez-Alzamora has focused on developing pharmaceutical solutions that enhance treatment efficacy and patient comfort. His innovative approaches have led to advancements in the way certain medications are administered and utilized in clinical settings.

Collaborations

Martínez-Alzamora has collaborated with notable colleagues, including Antonia Gómez Calvo and Nuria Sanz Menéndez. These partnerships have contributed to the successful development and refinement of his patented inventions.

Conclusion

Fernando Martínez-Alzamora's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare outcomes. His patents reflect a blend of scientific expertise and a commitment to addressing real-world medical challenges.